VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)

NCT01249664 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Myopia, Pathological

Interventions

BIOLOGICAL: VEGF Trap-Eye (BAY86-5321)
PROCEDURE: No Drug

Sponsor

Bayer

Collaborators

[object Object]